TotalMarketCap

Filana Therapeutics

FLNANasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$21.743 M

$0.45 -21.31%

Close of 6 Nov 2026

As of 6 Nov 2026, Filana Therapeutics (FLNA) has a market capitalization of $21.7M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

-$91.0M

Loss-making

Shares outstanding

50,269,619

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #377Mira PharmaceuticalsMIRA$23.0M
  2. #378CervoMedCRVO$22.7M
  3. #379Filana TherapeuticsFLNA$21.7M
  4. #380IGC PharmaIGC$21.6M
  5. #381Seres TherapeuticsMCRB$21.3M

What if Filana Therapeutics were worth as much as…

Open the what-if tool →

Gold $28.2T

$584,518.81

Per share 1,298,642× higher

Bitcoin $1.53T

$31,627.29

Per share 70,267× higher

Apple $5.02T

$103,829.46

Per share 230,681× higher

Or at a round number

$50.0M$100.0M$200.0M$500.0M

Where these numbers come from

Share counts and financials for Filana Therapeutics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.